Leh-Kiong Huon1,2,3,4, Stanley Yung-Chuan Liu4, Macario Camacho3,4,5, Christian Guilleminault6,7. 1. Department of Otolaryngology, Head and Neck Surgery, Cathay General Hospital, Taipei, Taiwan. 2. School of Medicine, Fu Jen Catholic University, Taipei, Taiwan. 3. Division of Sleep Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA. 4. Division of Sleep Surgery, Department of Otolaryngology-Head & Neck Surgery, Stanford University Medical Center, Stanford, CA, USA. 5. Division of Sleep Surgery and Medicine, Otolaryngology-Head and Neck Surgery, Tripler Army Medical Center, Honolulu, HI, USA. 6. Division of Sleep Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA. cguil@stanford.edu. 7. Stanford University Sleep Medicine Division, 450 Broadway Street, MC 5704, Redwood City, CA, 94063, USA. cguil@stanford.edu.
Abstract
PURPOSE: The purpose of this study was to evaluate the association between obstructive sleep apnea (OSA) and ophthalmologic diseases, specifically glaucoma, nonarteritic anterior ischemic optic neuropathy (NAION), retinal vein occlusion (RVO), central serous chorioretinopathy (CSR), and floppy eyelid syndrome (FES), by performing a systematic review and meta-analysis of published studies. METHODS: PubMed, Embase, and Scopus databases were searched for observational studies on OSA and its association with select ophthalmologic diseases. Data was pooled for random-effects modeling. The association between OSA and ophthalmologic diseases was summarized using an estimated pooled odds ratio with a 95 % confidence interval. RESULTS: Relative to non-OSA subjects, OSA subjects have increased odds of diagnosis with glaucoma (pooled odds ratio (OR) = 1.242; P < 0.001) and floppy eyelids syndrome (pooled OR = 4.157; P < 0.001). In reverse, the overall pooled OR for OSA was 1.746 (P = 0.002) in the glaucoma group, 3.126 (P = 0.000) in the NAION group, and 2.019 (P = 0.028) in the CSR group. For RVO, one study with 5965 OSA patients and 29,669 controls demonstrated a 1.94-fold odds increase in OSA patients. CONCLUSIONS: Our results suggest significant associations between OSA and glaucoma, NAION, CSR, and FES. Screening for OSA should be considered in patients with glaucoma, NAION, CSR, or FES.
PURPOSE: The purpose of this study was to evaluate the association between obstructive sleep apnea (OSA) and ophthalmologic diseases, specifically glaucoma, nonarteritic anterior ischemic optic neuropathy (NAION), retinal vein occlusion (RVO), central serous chorioretinopathy (CSR), and floppy eyelid syndrome (FES), by performing a systematic review and meta-analysis of published studies. METHODS: PubMed, Embase, and Scopus databases were searched for observational studies on OSA and its association with select ophthalmologic diseases. Data was pooled for random-effects modeling. The association between OSA and ophthalmologic diseases was summarized using an estimated pooled odds ratio with a 95 % confidence interval. RESULTS: Relative to non-OSA subjects, OSA subjects have increased odds of diagnosis with glaucoma (pooled odds ratio (OR) = 1.242; P < 0.001) and floppy eyelids syndrome (pooled OR = 4.157; P < 0.001). In reverse, the overall pooled OR for OSA was 1.746 (P = 0.002) in the glaucoma group, 3.126 (P = 0.000) in the NAION group, and 2.019 (P = 0.028) in the CSR group. For RVO, one study with 5965 OSA patients and 29,669 controls demonstrated a 1.94-fold odds increase in OSA patients. CONCLUSIONS: Our results suggest significant associations between OSA and glaucoma, NAION, CSR, and FES. Screening for OSA should be considered in patients with glaucoma, NAION, CSR, or FES.
Authors: Frank L Brodie; Emily S Charlson; Tomas S Aleman; Rebecca T Salvo; Dina Y Gewaily; Marisa K Lau; Neil D Farren; Stephanie B Engelhard; Maxwell Pistilli; Alexander J Brucker Journal: Retina Date: 2015-02 Impact factor: 4.256
Authors: Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley Journal: Am J Respir Crit Care Med Date: 2005-09-01 Impact factor: 21.405
Authors: Randy A Karger; W Abraham White; Won-Chan Park; A Gabriela Rosales; Jay W McLaren; Eric J Olson; John J Woog Journal: Ophthalmology Date: 2006-07-07 Impact factor: 12.079
Authors: Swarup S Swaminathan; Amitabha S Bhakta; Wei Shi; William J Feuer; Alexandre R Abreu; Alejandro D Chediak; David S Greenfield Journal: J Glaucoma Date: 2018-01 Impact factor: 2.503
Authors: Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor Journal: Drugs Date: 2020-04 Impact factor: 9.546
Authors: Emilio Pedrotti; Christian Luigi Demasi; Enrico Bruni; Francesca Bosello; Paolo Plinio Di Sarro; Mattia Passilongo; Adriano Fasolo; Nicola Gennaro; Alessandra De Gregorio; Marcello Ferrari; Giorgio Marchini Journal: BMJ Open Date: 2017-10-22 Impact factor: 2.692
Authors: Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani Journal: Ther Adv Ophthalmol Date: 2020-08-24
Authors: Nesreen E Morsy; Badawi E Amani; Ahmad A Magda; Awadalla J Nabil; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; David Warren Spence; Per O Lundmark; Nevin Fw Zaki Journal: Open Respir Med J Date: 2019-07-31